Journal
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
Volume 42, Issue 11-12, Pages 917-923Publisher
INFORMA HEALTHCARE
DOI: 10.3109/00365548.2010.511258
Keywords
-
Categories
Funding
- Region Hovedstaden
- Hvidovre Hospital's
- Thora og Viggo Grove's Mindelegat
- Christian Larsen og dommer Ellen Larsens Legat
- University of Copenhagen and Rigshospitalet
- Roche
- Bristol-Myers Squibb
- Merck Sharp Dohme
- GlaxoSmithKline
- Abbott
- Boehringer Ingelheim
- Janssen-Cilag
- Swedish Orphan
Ask authors/readers for more resources
The objective of this study was to determine the effect of highly active antiretroviral therapy (HAART) in human immunodeficiency virus (HIV)-infected patients infected through injecting drug use (injecting drug users, IDUs) compared to patients infected via other routes (non-IDUs). We conducted a nationwide population-based cohort study of all HIV-infected patients who initiated HAART during the study period of 1 January 1995 to 31 December 2007. We compared changes in CD4
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
